Lataa...

Did Clinical Trials in Which Erythropoietin Failed to Reduce Acute Myocardial Infarct Size Miss a Narrow Therapeutic Window?

BACKGROUND: To test a hypothesis that in negative clinical trials of erythropoietin in patients with acute myocardial infarction (MI) the erythropoietin (rhEPO) could be administered outside narrow therapeutic window. Despite overwhelming evidence of cardioprotective properties of rhEPO in animal st...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Talan, Mark I., Ahmet, Ismayil, Lakatta, Edward G.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2012
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3329541/
https://ncbi.nlm.nih.gov/pubmed/22529941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0034819
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!